Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Riboflavin 💬 1件: Riboflavin2件: Riboflavin; Vitamin B2; --7件: 38, 46, 96, 97, 162, 168, 265 💬
2 Rifampin 💬 1件: Rifampicin2件: Rifampicin; Rifampin; --9件: 6, 13, 17, 46, 84, 86, 93, 299, 338 💬
3 Ramipril 💬 1件: Ramipril1件: Ramipril; 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 46, 49, 66, 67, 113, 218, 257 💬
4 Ranitidine 💬 1件: Ranitidine1件: Ranitidine; 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬2件: 13, 65 💬
5 Ribavirin 💬 1件: Ribavirin2件: Copegus; RIBAVIRIN; --2件: 2, 96 💬
6 Rifabutin 💬 1件: Rifabutin1件: RIFABUTIN; --1件: 96 💬
7 Risperidone 💬 1件: Risperidone1件: Risperidone; 2件: DRD2,
HTR2A 💬
11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬5件: 8, 156, 179, 187, 206 💬
8 Ritonavir 💬 1件: Ritonavir2件: Norvir; Ritonavir; --3件: 2, 86, 265 💬
9 Rofecoxib 💬 1件: Rofecoxib1件: Rofecoxib; 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
10 Repaglinide 💬 1件: Repaglinide1件: Repaglinide; 2件: ABCC8,
KCNJ11 💬
4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬4件: 6, 21, 46, 299 💬
11 Riluzole 💬 1件: Riluzole2件: Rilutek; Riluzole; 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬9件: 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
12 Rebamipide 💬 1件: Rebamipide1件: Rebamipide; --4件: 46, 53, 97, 271 💬
13 Ramatroban 💬 1件: Ramatroban1件: Ramatroban; 2件: PTGDR,
TBXA2R 💬
3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬1件: 13 💬
14 Roxithromycin 💬 1件: Roxithromycin1件: Roxithromycin; --2件: 46, 299 💬
15 Rolipram 💬 1件: Rolipram1件: Rolipram; 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬
5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 8, 13 💬
16 Rifaximin 💬 1件: Rifaximin3件: Rifaximin; RIFAXIMINA; Xifaxan; --9件: 6, 65, 93, 94, 96, 97, 99, 296, 299 💬
17 Ramelteon 💬 1件: Ramelteon2件: Ramelteon; ROZEREM; 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 8, 46 💬
18 Rimabotulinumtoxin B 💬 1件: Botulinum toxin type B3件: Botulinum toxin type B; MYOBLOC; NEUROBLOC; 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 2, 6, 13, 51 💬
19 Rituximab 💬 1件: Rituximab6件: MabThera; Rituxan; Rituximab; Rixathon; Ruxience; Truxima; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
20 Rivastigmine 💬 1件: Rivastigmine3件: Exelon; Rivastigmine; Rivastigmine Transdermal System; 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬3件: 5, 6, 13 💬
21 Ranibizumab 💬 1件: Ranibizumab3件: Lucentis; Ranibizumab; RhuFab V2; 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬4件: 34, 166, 227, 301 💬
22 Ranolazine 💬 1件: Ranolazine3件: RANEXA; Ranolazina; Ranolazine; --6件: 2, 58, 86, 96, 113, 114 💬
23 Regadenoson 💬 1件: Regadenoson1件: Regadenoson; 1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 58 💬
24 Regramostim 💬 1件: Regramostim2件: GM-CSF; RhGM-CSF; 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
25 Rimonabant 💬 1件: Rimonabant2件: Acomplia; Rimonabant; 1件: CNR1 💬4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193 💬
26 Roflumilast 💬 1件: Roflumilast1件: Roflumilast; 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬
5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬4件: 84, 97, 206, 299 💬
27 Rotigotine 💬 1件: Rotigotine3件: NEUPRO; ROTIGOTINA; ROTIGOTINE; 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
28 Rufinamide 💬 1件: Rufinamide2件: Inovelon; RUFINAMIDE; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 144 💬
29 Rilonacept 💬 1件: Rilonacept1件: Rilonacept; 2件: IL1A,
IL1B 💬
45件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬4件: 51, 106, 107, 266 💬
30 Raltegravir 💬 1件: Raltegravir2件: ISENTRESS; Raltegravir; --4件: 13, 26, 93, 265 💬
31 Rivaroxaban 💬 1件: Rivaroxaban2件: RIVAROXABAN; Xarelto; 1件: F10 💬1件: Complement and coagulation cascades 💬4件: 46, 49, 91, 210 💬
32 Rupatadine 💬 1件: Rupatadine1件: Rupatadine; 2件: HRH1,
PTAFR 💬
4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 46 💬
33 Rabeprazole 💬 1件: Rabeprazole1件: Rabeprazole; 2件: ATP4A,
ATP4B 💬
4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 2, 51 💬
34 Raloxifene 💬 1件: Raloxifene2件: Raloxifene; Raloxifene hydrochloride; 2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 46 💬
35 Rasagiline 💬 1件: Rasagiline4件: AZILECT; Rasagilina; RASAGILINE; RASAGILINE MESYLATE; 1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬4件: 2, 5, 6, 17 💬
36 Remifentanil 💬 1件: Remifentanil2件: Remifentanil; Remifentanyl; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬2件: 6, 70 💬
37 Rilmenidine 💬 1件: Rilmenidine2件: HYPERIUM; Rilmenidine; 3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 8 💬
38 Risedronic acid 💬 1件: Risedronic acid3件: Risedronate; Risedronate sodium; Risedronic acid; 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 46, 50, 66, 93, 95, 96, 107, 113, 274 💬
39 Ropinirole 💬 1件: Ropinirole3件: REQUIP; Ropinirole; Ropinirole Hydrochloride; 3件: DRD2,
DRD3,
DRD4 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 74, 309 💬
40 Ropivacaine 💬 1件: Ropivacaine2件: Ropivacaine; Ropivacaine Hydrochloride Injection; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬4件: 22, 36, 46, 70 💬
41 Rosiglitazone 💬 1件: Rosiglitazone2件: Rosiglitazone; Rosiglitazone maleate; 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬5件: 46, 75, 97, 222, 265 💬
42 Rosuvastatin 💬 1件: Rosuvastatin3件: Crestor; Rosuvastatin; ROSUVASTATIN CALCIUM; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
43 Reparixin 💬 1件: Reparixin1件: Reparixin; 2件: CXCR1,
CXCR2 💬
7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬2件: 298, 299 💬
44 Reslizumab 💬 1件: Reslizumab1件: Reslizumab; 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 98 💬
45 Romiplostim 💬 1件: Romiplostim2件: NPLATE; Romiplostim; 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65 💬
46 Raspberry 💬 1件: Raspberry1件: Raspberry; --1件: 97 💬
47 Riociguat 💬 1件: Riociguat2件: Adempas; Riociguat; 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬
11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 51, 84, 86, 88, 225, 299 💬
48 Rontalizumab 💬 1件: Rontalizumab1件: Rontalizumab; 13件: IFNA1,
IFNA10,
IFNA13,
IFNA14,
IFNA16,
IFNA17,
IFNA2,
IFNA21,
IFNA4,
IFNA5,
IFNA6,
IFNA7,
IFNA8 💬
25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
49 Remestemcel-L 💬 1件: Remestemcel-L3件: Adult human mesenchymal stem cells; Prochymal; Remestemcel-L; --3件: 85, 96, 97 💬
50 Rilpivirine 💬 1件: Rilpivirine1件: Rilpivirine; --1件: 256 💬
51 Royal jelly 💬 1件: Royal jelly1件: Royal jelly; --1件: 49 💬
52 Ruxolitinib 💬 1件: Ruxolitinib1件: Ruxolitinib; 2件: JAK1,
JAK2 💬
35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬3件: 60, 65, 228 💬
53 Rigosertib 💬 1件: Rigosertib1件: Rigosertib; 1件: PLK1 💬4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 36 💬
54 Romosozumab 💬 1件: Romosozumab2件: Evenity; ROMOSOZUMAB; 1件: SOST 💬2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬1件: 274 💬
55 Ralinepag 💬 1件: Ralinepag1件: RALINEPAG; 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
56 Relebactam 💬 1件: Relebactam1件: Relebactam; --1件: 299 💬
57 Rurioctocog alfa pegol 💬 1件: Rurioctocog alfa pegol1件: Rurioctocog alfa pegol; --1件: 288 💬
58 Rasagiline tartrate 💬 1件: Rasagiline4件: Azilect; Rasagilina; Rasagiline; Rasagiline mesylate; 1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬4件: 2, 5, 6, 17 💬
59 Risankizumab 💬 1件: Risankizumab1件: Risankizumab; 1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬4件: 37, 96, 97, 271 💬
60 Ravulizumab 💬 1件: Ravulizumab2件: RAVULIZUMAB; Ultomiris; 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109 💬
61 Rimiducid 💬 1件: Rimiducid1件: Rimiducid; 1件: CASP9 💬35件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬6件: 19, 60, 65, 284, 285, 326 💬
62 Reproxalap 💬 1件: Reproxalap1件: Reproxalap; --1件: 160 💬
63 Relacorilant 💬 1件: Relacorilant2件: CORT125134; Relacorilant; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75 💬
64 Reldesemtiv 💬 1件: Reldesemtiv2件: CK-2127107; Reldesemtiv; 1件: TNNC2 💬1件: Calcium signaling pathway 💬2件: 2, 3 💬
65 Risdiplam 💬 1件: Risdiplam2件: EVRYSDI; Risdiplam; 1件: SMN2 💬1件: Nucleocytoplasmic transport 💬1件: 3 💬
66 Ravagalimab 💬 1件: Ravagalimab1件: Ravagalimab; 1件: CD40 💬17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬2件: 53, 97 💬
67 Rozanolixizumab 💬 1件: Rozanolixizumab1件: ROZANOLIXIZUMAB; 1件: FCGRT 💬1件: 💬3件: 11, 14, 63 💬
68 Remibrutinib 💬 1件: Remibrutinib1件: Remibrutinib; 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 13, 53 💬
69 Regadenoson 💬 1件: Regadenoson1件: Regadenoson; 1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 58 💬